Search results
Moderna's mRNA-1283 vaccine shows promise in Phase 3 trial By Investing.com
Investing.com· 18 hours agoModerna , Inc. (NASDAQ:MRNA) has announced successful results from the Phase 3 trial of its...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 3 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 11 hours agoBoth experts caution that, anytime you’re spending time in crowded places, there’s still some risk...
Moderna's combo COVID and flu shot offers strong immunity in older adults during late stage trial
Good Morning America via Yahoo News· 4 days agoModerna's combo flu and COVID vaccine provided a strong immune response in older adults, with levels...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation...
Digital Journal· 20 hours agomRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax ...
FDA approves first RSV vaccine for at-risk adults in their 50s
CBS News· 6 days agovaccine for respiratory syncytial virus down to age 50 years old, to those who are at higher risk of...
FDA clears GSK's RSV vaccine for adults ages 50-59
United Press International via Yahoo News· 5 days agoThe U.S. Food and Drug Administration on Friday approved GSK's respiratory syncytial virus vaccine for high-risk adults ages 50 to 59, expanding the...
Celebrity doctors promoted Covid vaccine without declaring payments
The Telegraph via Yahoo News· 6 days agoThe pharmaceutical watchdog has been urged to investigate after a string of celebrity doctors took...
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
CNBC· 6 days agoThe Food and Drug Administration on Friday expanded the approval of GSK's respiratory syncytial...
InnovationRx: Tarsus Pharmaceuticals Takes Aim At Disease-Causing Bugs
Forbes· 2 days agoAround 25 million Americans are affected by the eye disease Demodex blepharitis, which is caused by...